JP
Publications
120
Views
63,007
Downloads
8,826
Supervised works
8
Items per page
1 - 120 of 120
Title Published in Access level OA Policy Year Views Downloads
Circadian organization of lipid landscape is perturbed in type 2 diabetic patientsCell reports. Medicine
accessLevelPublic
2023 167 65
The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomasEndocrine
accessLevelPublic
2023 91 19
Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-debridement Antibiotic Treatment for 10 versus 20 daysAnnals of surgery
accessLevelPublic
2022 145 186
Growth differentiation factor-15 prevents glucotoxicity and connexin-36 downregulation in pancreatic beta-cellsMolecular and cellular endocrinology
accessLevelPublic
2022 51 63
Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patientsActa Physiologica
accessLevelRestricted
2021 308 3
Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatmentPhysiological reports
accessLevelPublic
2021 197 98
Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: A prospective, randomized, non-inferiority pilot trialClinical Infectious Diseases
accessLevelPublic
2020 223 297
Analogues du GLP-1 en 2019 : pour qui et comment ?Revue médicale suisse
accessLevelRestricted
2019 375 1
Faut-il prescrire plus d'inhibiteurs SGLT-2 ?Revue médicale suisse
accessLevelPublic
2019 260 91
Cellular circadian period length inversely correlates with HbA1c levels in individuals with type 2 diabetesDiabetologia
accessLevelRestricted
2019 443 5
Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysisThrombosis Research
accessLevelRestricted
2019 285 1
Validation of molecular biomarkers for preoperative diagnostics of human papillary thyroid carcinoma in fine needle aspiratesGland Surgery
accessLevelRestricted
2019 445 5
Observance thérapeutique et empilage médicamenteuxRevue médicale suisse
accessLevelPublic
2018 323 116
Composite pheochromocytoma with neuroblastoma: a case report20th European Congress of Endocrinology
2018 115 1
Time zones of pancreatic islet metabolismDiabetes, Obesity and Metabolism
accessLevelRestricted
2018 416 0
Identification of Differential Transcriptional Patterns in Primary and Secondary HyperparathyroidismJournal of Clinical Endocrinology and Metabolism
accessLevelRestricted
2018 598 4
Consequences of the Adoption of the IADPSG versus Carpenter and Coustan Criteria to Diagnose Gestational Diabetes: A Before-After ComparisonExperimental and Clinical Endocrinology and Diabetes
accessLevelRestricted
2018 462 2
Manifestations musculosquelettiques du diabète sucré : une complication fréquenteRevue médicale suisse
accessLevelRestricted
2017 342 0
Anti-CTLA-4 Monoclonal Antibodies Induced Hypophysitis: Case Report and Literature ReviewAnnals of Clinical Case Reports
accessLevelPublic
2017 410 111
Traitement du diabète de type 2 : risques et bénéfices de la chirurgie métaboliqueRevue médicale suisse
accessLevelRestricted
2017 333 0
Traitement du diabète: quand faire appel au diabétologue?Revue médicale suisse
accessLevelPublic
2017 338 132
Association des analogues du GLP-1 et des inhibiteurs du SGLT2 : de nouvelles perspectives ?Revue médicale suisse
accessLevelRestricted
2017 343 0
The search for preoperative biomarkers for thyroid carcinoma: application of the thyroid circadian clock propertiesBiomarkers in medicine
accessLevelRestricted
2017 509 1
Pancreatic α- and β-cellular clocks have distinct molecular properties and impact on islet hormone secretion and gene expressionGenes and Development
accessLevelPublic
2017 544 12
Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examplesJournal of Immunological Methods
accessLevelRestricted
2017 359 1
Prévention et guérison du diabète : est-ce possible ?Revue médicale suisse
accessLevelRestricted
2016 419 0
Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinomaOncotarget
accessLevelPublic
2016 602 204
Functional and Molecular Adaptations of Enteroendocrine L-Cells in Male Obese Mice Are Associated With Preservation of Pancreatic α-Cell Function and Prevention of HyperglycemiaEndocrinology
accessLevelRestricted
2016 496 0
Effects of liver transplantation on endocrine function: a systematic reviewLiver international
accessLevelRestricted
2016 502 4
α-Cell Dysfunctions and Molecular Alterations in Male Insulinopenic Diabetic Mice Are Not Completely Corrected by InsulinEndocrinology
accessLevelRestricted
2016 546 1
Comment faire pour prévenir le diabète de type 2 en Suisse?Revue médicale suisse
accessLevelRestricted
2016 384 2
Dysthyroïdies liées à une surcharge iodéeRevue médicale suisse
accessLevelRestricted
2016 342 0
Insuline et antidiabétiques oraux : comment les associer dans la pratique ambulatoire ?Revue médicale suisse
accessLevelRestricted
2016 446 3
Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathwayProceedings of the National Academy of Sciences of the United States of America
accessLevelPublic
2015 506 228
Thyroid Circadian Timing: Roles in Physiology and Thyroid MalignanciesJournal of biological rhythms
accessLevelRestricted
2015 609 0
Free Fatty Acids Impair FGF21 Action in HepG2 CellsCellular physiology and biochemistry
accessLevelPublic
2015 512 277
Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitisCanadian journal of diabetes
accessLevelRestricted
2015 511 0
Acute painful diabetic neuropathy: an uncommon, remittent type of acute distal small fibre neuropathySchweizerische medizinische Wochenschrift
accessLevelRestricted
2015 555 2
Erreurs innées du métabolisme: transition enfant-adulteRevue médicale suisse
accessLevelRestricted
2015 546 2
Statins and Diabetes: The Plot ThickensJournal of general internal medicine
accessLevelRestricted
2015 429 0
Le diabète en 2015 : en augmentation constante, mais avec une offre thérapeutique qui s'élargitRevue médicale suisse
accessLevelRestricted
2015 365 1
Baisse de la déhydroépiandrostérone avec l'âge : pertinence clinique et intérêt thérapeutiqueRevue médicale suisse
accessLevelRestricted
2015 502 1
Restoration of adrenal function after bilateral adrenal damage due to heparin-induced thrombocytopenia (HIT): a case reportJournal of medical case reports
accessLevelPublic
2015 625 260
Endocrinologie :l'hyperparathyroïdie primaire asymptomatique en 2014Revue médicale suisse
accessLevelRestricted
2015 453 1
Identification of new biomarkers for human papillary thyroid carcinoma employing NanoString analysisOncotarget
accessLevelPublic
2015 708 379
DiabétologieRevue médicale suisse
accessLevelRestricted
2015 451 0
Analogues du GLP-1 versus inhibiteurs du SGLT-2 pour les diabétiques de type 2 obèsesRevue médicale suisse
accessLevelRestricted
2015 462 1
Syndrome des ovaires polykystiques : quoi de neuf ?Revue médicale suisse
accessLevelRestricted
2015 464 1
EndocrinologieRevue médicale suisse
2014 517 0
Maladies hépatiques chroniques et diabèteRevue médicale suisse
accessLevelRestricted
2014 445 0
Le concept de parcours de santé ou la difficile révolution de la prise en charge des maladies chroniquesRevue médicale suisse
accessLevelRestricted
2014 432 0
Foxa1 and Foxa2 regulate α-cell differentiation, glucagon biosynthesis, and secretionEndocrinology
accessLevelRestricted
2014 582 0
La testostérone : un traitement pour la prévention des maladies cardiovasculaires ?Revue médicale suisse
accessLevelRestricted
2014 457 0
Traitement combiné d'insuline et d'analogue du GLP-1 : qu'en attendre ?Revue médicale suisse
accessLevelRestricted
2014 523 0
Quelle insuline pour quel patient en 2014 ?Revue médicale suisse
accessLevelRestricted
2014 403 0
Glucagon: the renewal of an old hormone in the pathophysiology of diabetesJournal of diabetes and its complications
accessLevelRestricted
2013 547 0
Autonomous and self-sustained circadian oscillators displayed in human islet cellsDiabetologia
accessLevelPublic
2013 652 151
Non-alcoholic fatty liver disease and insulin resistance: from bench to bedsideDiabetes & metabolism
accessLevelRestricted
2013 569 0
Circadian clock characteristics are altered in human thyroid malignant nodulesThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2013 677 2
A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial?Rejuvenation research
accessLevelPublic
2013 630 681
Implications of somatostatin analogues in the treatment of acromegalyEuropean endocrinology
accessLevelPublic
2013 337 174
Hypoglycémie non diabétique : diagnostic et prise en chargeRevue médicale suisse
accessLevelRestricted
2013 589 2
Sport et diabète de type 1Revue médicale suisse
2013 601 0
Biofeedback can reduce foot pressure to a safe level and without causing new at-risk zones in patients with diabetes and peripheral neuropathyDiabetes/metabolism research and reviews
accessLevelRestricted
2013 565 1
Maladies chroniques : le politique doit s'engager !Revue médicale suisse
accessLevelRestricted
2013 394 1
Diabète de la personne âgée : une prise en charge sur mesureRevue médicale suisse
accessLevelRestricted
2013 549 0
Biological rhythms and preeclampsiaFrontiers in endocrinology
accessLevelPublic
2013 687 498
Pax6 is a key component of regulated glucagon secretionEndocrinology
accessLevelRestricted
2012 1,010 0
Sommeil et diabèteRevue médicale suisse
accessLevelRestricted
2012 458 0
Diabète et stéatose hépatique non alcooliqueRevue médicale suisse
accessLevelRestricted
2012 551 0
Néphropathie diabétiqueRevue médicale suisse
accessLevelRestricted
2012 584 1
Hypothermia is a frequent sign of severe hypoglycaemia in patients with diabetesDiabetes & metabolism
accessLevelRestricted
2012 597 0
Antidiabetic drugs and kidney disease--recommendations of the Swiss Society for Endocrinology and DiabetologySchweizerische medizinische Wochenschrift
accessLevelPublic
2012 1,902 1,217
La médecine personnalisée et la face cachée de la luneRevue médicale suisse
accessLevelRestricted
2012 434 1
Pax6 is crucial for β-cell function, insulin biosynthesis, and glucose-induced insulin secretionMolecular endocrinology
accessLevelRestricted
2012 581 0
Glucagon gene expression in the endocrine pancreas: the role of the transcription factor Pax6 in α-cell differentiation, glucagon biosynthesis and secretionDiabetes, obesity & metabolism
accessLevelRestricted
2011 585 0
Glucagon responses of isolated α cells to glucose, insulin, somatostatin, and leptinEndocrine practice
2011 541 0
Hémoglobine glyquée: nouvel outil de dépistage?Revue médicale suisse
accessLevelRestricted
2011 575 1
Prise en charge du diabète gestationnel: nouvelles connaissances et perspectives futuresRevue médicale suisse
accessLevelRestricted
2011 622 1
Prise en charge du diabète et réseaux médicaux: est-ce la solution?Revue médicale suisse
accessLevelRestricted
2011 453 0
Diagnostic et traitement de l'insuffisance pancréatique exocrine lors d'un diabèteDiabetes, Stoffwechsel und Herz
2011 516 0
Importance de la décharge dans le traitement des lésions du pied diabétiqueRevue médicale suisse
accessLevelRestricted
2011 505 1
Multislice gated-computed tomography of cardiac paragangliomasJournal of the American College of Cardiology
accessLevelRestricted
2010 464 0
Pax6 controls the expression of critical genes involved in pancreatic {alpha} cell differentiation and functionThe Journal of biological chemistry
accessLevelRestricted
2010 560 1
Comment minimiser la prise de poids secondaire au traitement d'insuline?Revue médicale suisse
2010 533 0
L'aspirine en prévention primaire chez les patients diabétiquesRevue médicale suisse
2010 440 0
Insuline et cancer: mythe ou realité?Revue médicale suisse
2010 561 0
Diabète et cancer: une association pernicieuseRevue médicale suisse
2010 603 0
Treating type 2 diabetes: how safe are current therapeutic agents?International journal of clinical practice
accessLevelRestricted
2009 511 0
Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2Molecular and cellular biology
accessLevelRestricted
2009 560 0
Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year markAmerican journal of transplantation
accessLevelRestricted
2009 888 6
Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trialDiabetes, obesity & metabolism
accessLevelRestricted
2008 820 8
Mucocutaneous papillomatous papules in Cowden's syndromeClinical and experimental dermatology
accessLevelRestricted
2008 510 0
Motesanib diphosphate in progressive differentiated thyroid cancerThe New England journal of medicine
accessLevelRestricted
2008 496 0
Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocolAmerican journal of transplantation
accessLevelPublic
2006 791 238
Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic controlAmerican journal of transplantation
accessLevelPublic
2006 796 263
Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and functionThe Journal of clinical endocrinology and metabolism
accessLevelPublic
2005 638 352
The zinc finger-containing transcription factor Gata-4 is expressed in the developing endocrine pancreas and activates glucagon gene expressionMolecular endocrinology
accessLevelRestricted
2005 552 0
Pax2 mutant mice display increased number and size of islets of Langerhans but no change in insulin and glucagon contentEuropean journal of endocrinology
accessLevelRestricted
2004 626 0
Islet autotransplantation for the prevention of surgical diabetes after extended pancreatectomy for the resection of benign tumors of the pancreasTransplantation proceedings
accessLevelRestricted
2004 733 0
Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantationsTransplantation proceedings
accessLevelRestricted
2004 722 1
Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1The Journal of clinical endocrinology and metabolism
accessLevelRestricted
2003 579 0
Islet autotransplantation after left pancreatectomy for non-enucleable insulinomaAmerican journal of transplantation
accessLevelPublic
2003 753 570
Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipientsTransplantation
accessLevelRestricted
2003 676 1
Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcriptionDiabetologia
accessLevelPublic
2003 628 142
Molecular detection of circulating beta-cells after islet transplantationDiabetes
accessLevelPublic
2002 652 323
An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling eventsDiabetologia
accessLevelRestricted
2002 427 0
Human islet allotransplantation with Basiliximab in type I diabetic patients with end-stage renal failureTransplantation proceedings
accessLevelRestricted
2002 648 0
Hepatic nuclear factor-3 (HNF-3 or Foxa2) regulates glucagon gene transcription by binding to the G1 and G2 promoter elementsMolecular endocrinology
accessLevelRestricted
2002 488 0
Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiationThe Journal of biological chemistry
accessLevelPublic
2001 610 1,607
Insulin independence and normalization of oral glucose tolerance test after islet cell allotransplantationTransplant international
accessLevelRestricted
2001 740 0
Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantationsTransplantation
accessLevelRestricted
2000 650 0
Le traitement du diabète par transplantation: quelles sont les indicationsMédecine et hygiène
accessLevelRestricted
2000 604 0
Transplantation d'îlots de Langerhans: Quo vadis?Médecine et hygiène
accessLevelRestricted
1998 605 0
Results of human islet allotransplantation in cystic fibrosis and type I diabetic patientsTransplantation proceedings
accessLevelRestricted
1998 684 0
Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenesProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
1994 574 1
Air in the bones: multifocal anaerobic osteomyelitis associated with oat cell carcinomaBMJ. British medical journal
accessLevelRestricted
1985 531 0
Increased clearance and degradation of [3H]insulin in streptozotocin diabetic ratsThe Journal of clinical investigation
accessLevelRestricted
1981 557 0
Resistance against subcutaneous insulin successfully managed with aprotininLancet
1980 619 0
Inhibition of degradation of insulin by ophthalamic acid and by a bovine pancreatic proteinase inhibitorBiochemical journal
accessLevelRestricted
1979 591 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack